Letter to Congress Requesting Action on LDT Oversight

Molecular tests are critical to safe, effective care for cancer patients, yet the oversight system for laboratory developed tests is in need of updating.  This letter, co-signed by 33 organizations, request that Congress act to ensure appropriate diagnostic oversight.